Registered number: 06641016 Charity number: 1126927 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES (A Company Limited by Guarantee) TRUSTEES. REPORT, INDEPENDENT EXAMINER'S REPORT AND FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2021 ABIXV23U 15112r2022 COMPANIES HOUSE A19
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limited by Guarnntee} CONTENTS Page Reference and Administrative Details of the Charity. its Trustees and Advlse Trustees. Report Independent Exafflinerfs Report Statement of Financial kiivities 2-10 11-12 13 Balance Sheet 14 Statement of Cash Flows 15 Notes to th• Financial Statements 16-32
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCEirr DIABETES IA Company Limited by Guarantee) REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY. ITS TRUSTEES AND ADVISERS FOR THE PERIOD ENDED 31 DECEMBER 2021 Trustees PTofessN David Maahs. Secretary General IresKJned 16 October 20201 Professor Kim Donaghue, President (resigned 16 October 20201 Dr Lars KTogvold. Treasurer Dr Carine de Beaufort PreSent (appointed 16 October 20201 Dr Jamie Wood. Secretary General lapwinled 16 October 2020) Company registered number 08641016 Charity r8gl$tered number 1126927 Registerèd office Ellenborough House Wellington Street Cheenharn Gloucestershire GL50 1YD Management Company l K.l.T. Group GmbH Principal Office Company se¢retary Dr Jamie Wood Independent Examiner Tara Weslcott FCCA. Crowe U.K. LLP Fourth Floor St James House Sl James Squa Cheltenham GL50 3PR Bankers Commerzbank Bedin-Gedathtniskirche Kurfu'fslendamm 237 10719 Berlin Germany Lbyds Bank PIC Rotunda Montpellier Cheltenham Gloucestershire GL50 1SH Page 1
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limited by Guarantee) TRUSTEES. REPORT FOR THE PERIOD ENDED 31 DECEMBER 2021 The Tnjslees under Chanty Law, who are also Ihe Th"rectots under Company Law, present their report and the financial 5talemenls of the Charty for the period ended 31 December 2021. This report has been prepared in accordance with the special provisi$ rekts.ng to Companies subjed lo the small companies regime within Part 15 of the Compan$ Act 20(. The Intemalional Souety for Ped[atr and Adolescent Diabetes - ISPAD - is a Charitab company, limrted by guarantee. incorporated on 8 Juty 2008 (registration number 066410161 and registered as a charity on 25 November 2008 Icharity number 11269271. STRUCTURE. GOVERNANCE AND MANAGEMENT Govèming Document The Intemalional S¢xiely for Pediatric and AdoFescent Diabetes {ISPAD or the SIXty} is govemed by ((5 Memorandum and ArtKtes of Association dated 8 Juty 2008 {amended 28 October 20161," and the UK Charity Governae Code. Prlnclpal Activity The prinapal aclivrty of ISPAD is to improve the INes of children. adolescents and young adults with diabetes worf.de, whh is accomp115hed by providiry forums, both Wren (gukletinesl and fa¢e-lo-face Iscienlrfic meetings. science s¢hoDls for physicians and for alld healthcare profesSnal$, and postgraduate courses). to physlan$ and healthcare professionals who prowde care for young people wi(h diabetes. To adVae further these aims. ISPAD advocates throughout the wortd for the appropriate Provision of medical care and assists inlemalional organisalions and heatth servites in the delivery of crrtul diabetes self4are supplies. such as insulin and glucose lest stn"ps. together with eduCatnal and promots'onal material for all children and adolescents with diabetes. Organisational Management Each officer of the Chanty has a role and responsibilities that are enumerated in the goveming document. The Society's focus on ScnCe, Ad¢Y and EducatK)n is ensured by the officers of the Society who serve as Trustees. They have the uttimate reSpsbIlIty for fiscal and other decisions in accordance with the Memoranduffl and ArtKles of As5walion, and any bylaws. They consult wrth the advisory council composed of members of the Society ele¢led each year al Ihe Annual Conference. Advisory council members are specifically sought from different regions of the world so that they are represenlalive of the membership as a whole. The advisory council formally meets wrth the board fvce each year. Betsyeeft meetings infom7ation is exchar>ged by e-mail and regular ccnference calls. The dissemination of inf0m8tn important issues doès not red to waf( for fonnal meetings. The Trustees relain an ¢yganlsatnal management group {K.l.T_ Group GmbH, Berfin. Germany) who deal with the day-to4ay activities of the Sc¢ty and athses the Tru51ees in this regard. They have the ability lo allocate their employees in any manner that best seNes the Soa"ety and are granted a InSe to organi5e and manage the Annual Conference. the venue for which is selected by the Execulive Board. K.l.T_ Group reviews the locations. budgets and logist for the Society and Sn$ the contrads between the rnanagemenl group and venues and exhibitors. K.l.T. Group also cc41aborates wrth and prowdes logislKal support to the local conveners and inlefnalional Scientific Ctynmrttee, which creates the scienlrfic program and selects speakers. The management group maintsins for the ordS of daY4laY financ1 transactions and provides reports to the Treasurer and other Trustees at regular intervals. K.l.T. Group processes receipts and transfers funds from the Society's accounts Iu5ed for day-laY activrts1 with the approval of the Treasurer, or the Trustees as a whole, during Twstee meelings or after discussKins wilh Trustees. They or9anise the venue and related active$ Directors, meetings. The Charity retains tr•)th an accounting fimi and soliciiors. These advise the Trustees on govemance. legd. and financial issues. Rgcruitment and Training of TN$tees The Trustees of the Society are the curTent seNing officers of the Society. The Trustees are elected by the Page 2
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limited by Guarantee) TRUSTEES. REPORT ICONTINUEOI FOR THE PERIOD ENDED 31 DECEMBER 2021 rnembers at the Annual Conference. The processes for nomination elect of the Trustees are OLrtlined in the Articles and Memorandum (amended 12 October 2012 to allow electronic voting). Trustees have been membets of the Socth for many yeats and have contn"buted to the Society in many arenas., e.g., serving on the Advisory coun1. organising one or more of the Annual Scientific meetings. $cnCe schools or poslgraduale courses. Trustees have contributed to the soc$ efforts in Soenee. Educalion and AV¢¢y. which are the pillals of the Sociely. NY elected Tru51ees spend one year as Tru5teekcl and attend the Boardrrru51ee meeting5 to gain experience in the Societvs ath.vrts'. charity governance. ffinance5, grant pro$s1n9/appT0ValS and other issues involving the organisatKJn and wnning of the Society. Trustees musl be members in good standing of the Society and have participated in the activitres in leadetship roles. They Teceive fomial infomation about the role and responsibilrties of a Trustee. and undertake seff-paced leaming from documents available through the Charity Commission. The year spent seNng as Twsteeolect alkhvs on the job expenence, guidance and educali¢)n from the current Trustees prior to assuming the responsibilty of a Trustee. Structure and Relalion$hlps The TrusteeslBoard of Direclors communicate wrth each other (usually via email) almost daily on the management and 1ction of the Charty. A gUlar formal video conference meeting is arranged monthty betsveen the Officers and the Administration Company. The Trustees relain an organisational management group lo assist th the actual day-to4ay management of the Charity and the Board has diwt ¢)versight of their acliwlies. The Souety contracts with the management group to organise and manage the Annual Conferenee. The management group also provide material support for meetings. Ofganises Ihe Annual Report vthh the Trustees. whh is prepared for distribution at the Annual General Meeting land by e-mail to the enkn.re membership) and provKles a posl-conference report for the .Truslees after the Annual Conference. Fonnal management reports a presenled to the Trustees at faCtt>faCe meetings at least tw'ce per year. A wrrtten report is presented to the Trustees an(J membets al the Annual General Meetsng. Information is exchanged by e-mail or telephone frequently on an 'as needed. 51$. Financi81 fftports a given lo the Treasuref (egularly. and the Tiuslees are updated regulady. The Trustees. on behaw of the Society. have e$lablished a contract Wiley, the publisher of the Stxiety's joumal, Pedialri¢ Diabetes. to provide subscriptions lo PedKitri¢ Diabetes to all ISPAD members. The Trustees, on behalf of the Society. provide scientific oversKJhl and work Close wlh the conveners on the program of the Annual Cortference. The Stxiety has established agreements of cooperation, colLqboratKJn and Memoranda of Understanding with other Charities. companies and Medical Professional Organis8tsons with similar objectives and aims on a need's basis. The Trustees ¢tract for fxility space, aud>visual supplies and support. and fcK#J for the Winter administration meeting (usually held during the intemalional conference on Advanced Technobgie5 & Treatment5 for Diabete51 and the June meeting Usual held during the Amer¢can Diabetes Associats"on Annual Scientific Meeting in the United States. The Trustees sel poIleS and guidelines for ¢xgani%ing and running the Annual Conference. Rlsk MaDagemenl By conlfactual agreement. the management group shares the finanaal risk for the Annual Conference, whieh usualty attfacls al least 1.000 attendees from around the worfd. ISPAD maintains a subslanlial amount of reserve funds and does not spend money unless convinced that so doing is consislenl with the mission of ISPAD. likely to be benefual and will not deplete its reSee$. Page 3
THE INTERNATIONAL SOCIEff FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limited by Guarnntee) TRUSTEES. REPORT ICONTINUEDI FOR THE PERIOD ENDED 31 DECEMBER 2021 The Trustees conduct an annual revi of alt tw of risk by whith the S¢xiety may be affected. HaviTrg reviewed these risks, the Trustees are sa115fied that apprcfjriate systems are in place lo mana9e exposure ta major risks. The Society holds Trustee lialx.lty insurance. Govemance The Tfuslees of ISPAD are committed lo the Sociws mission aThJ have ioined it5 board because they want lo help the charity most effectivety carry out rts mission for the benefft of patients and familie5 Wrth diabetes. Trustees fully recognise that meeting their ¢haritYs stated public benefrt is an ongoing requirement, understand their roles and legal respon5ibilrties, and are committed to good govemance. and wish to contribute to ISPAD's eonlinued inwrovement. The board acts with integrty. adoptiryJ values and creating a culture that helps xhieve the organisalion's charitable purposes. The l)oard is aware of the Knportance of the public's conf*Jence and twst in charities, and Iruslees undertake their duties accordingty. Trustees have the ulkn'mate fKluciary responsibilty for managing ISPAD'S funds and assets, protecting ts reputation. and maintaining the respect of benefuaries, other stakeholders and the public by behaving with integrity al all times. even when drfficult or unpopular de¢L%nS we quIred. The board leads the organisation in being transparent and accountab. The charity is open in ils work, unless the is good reason for il nol lo be. The Publ,$ trust that a charity is delivering a publi¢ benefrt is fundamental lo ils ieputalion success. Making accountabilty real, Ihrovgh genuine and open tWCtrWay communication that celebTales suc¢esses and demonstrates wllingness lo frcm mistskes. helps to build this trust and confidence and earn legrtimacy. OUR VISION, MISSION. AND VALUES Our Vision A better wortd for chiklren. adolescents and young ad vmh diabetes. Migsion Statement To bring together professkjnals from vauS disciplines wrth an interest in clinical care, seienee. education and advocY to prevent. treat or cure al fonns of diabetes youth. By promoling neOrking arKJ collaboration. our aim5 are.. To ensure appropriate treatment is available. indudng medKation. sew-monitoring equipment and supplies,. To increase awareness of all lypes of diabeles and prevent delayed dragnosis". To reduce the morbidity and mortalrty caused by acute and chronic corry)lulNJns". To ensure provision of education to youth, families and other caregivers.. To promote education of diabetes healthcaie teams workywide., To foster diabetes search." and To prepare and ¢Jisseminale dinical practice guideline5 and standards. Our Values Excellence In care, based on rigorous and ethical research with SPect for the Indal child. alolescent and family and by creating, evaluating and disseminating dobetes kn¢ywledge. Collaboratlon The sIety cdlab¢yales with national and international paInt and profrssional organisalions. healthcare providers, policy makers and companh?s that make prfylucts or Prode seNces for children wrth diabetes. Page4
THE INTERNATIONAL SOCIETY FOR PECMATRIC AND ADOLESCENT DIABETES IA Company Limited by Guarantsel TRUSTEES. REPORT {CONTINUEDI FOR THE PERIOD ENDED 31 DECEMBER 2021 Advocacy For children and Caregivers lo improve awareness that diabetes is dsfferent foT children compared lo adults". to end discrimination based on a child's diabetes.. and lo obtain increased funding for diabetes treatment. research and prevention. To promote the care of children and adrJescent$ with all fomis of diabetes mellrtus." To be an advocate for children and adolescents with all foms of diabetes mellrtus." and To enCouge and support basic, clinical. ephdemiological, heatth. economic and all other relevant research conceming pediatric and addescent diabetes mellrtus. Public Benefit Please see beh)w a summary of the piincipal aEIMbes arKI accomplishmen15 for the year which ISPAD ha5 carried out for the public benefit In the furtherance of these objectives. the ISPAD Trustees have complied wrth the duty Section 17 of the Charities Act 2011 to have due regard to the Charrty CnMIssIon,S published general and releVt sub-sector guidance conceming the operation of the PLtblic Benefft reqU1ment under that Act. PRINCIPAL ACTIVITIES AND ACCOMPUSHMENTS Education The extensive Clinical PraCte Guidelines, plIshed in 2018. ¢ontinue lo be promulgated and made available on the Societys website and published in pediatr Diabetes. the Society's joumal. The Clinical Pradice Guidelines are an up404ate reference for all those con¢emed wTrth the management of childhood diabetes vrldwIde. An extenswe upd*e and revision of the Clinul Pra¢b'ce Recommendations will be published in October 2022.The Guidelines are developed and wrrtlen by membets of the ScKiety. led by an edrtorial team. In addrtion. an external proje¢l officer has been appointed to take a lead in supporting the edrtorial team lo ensure the guidelines meet inlernatNinal standards for dinical guidelines ensure harmonisalion of recOmmendatns. content, Language and evidence grading across chaplers. The Guidelines are evidenc&based and are written using a review prccess involving input from the entire membership. led by our excellent and enthusiaslrc volunteer editorial learn. A copy of ea¢h chapter is available for download by anyone Inol ortty for the members) al no cost from our websrte www.ispad.org. Tran51alions into other languages a encouraged wrth no charge from ISPAD who coordinates these efforts lo avoid redundant translations. In 2020 and 2021. due to the pandemic. ISPAD had to postpone or translafe many of its ath"vth"e$ in a virtual formal. Virtual educational acttvities included quarterty webinars. Virtual Science Schools for Physicians and Healthcare Profesonal5, a5 weu as Poslgraduale Courses. Advocaey ISPAD collabofatgs closety wilh 'Lrfe for a Chikl. and 'Changing Diabetes in Children, two major programs whose aim is lo improve access lo essentkn drabetes medicTnes (insulin) and supplies for chiklren in the developing world. ISPAD continues to work Yh European Unron partners to rfflprove the qualrty of care throughout the world. Science The Annual Conferences invofve presentation of research activrties, state4)f-thevart lectures and topic specific symposia. In 2020 and 2021, ISPAO'S Annual Conference took place virtualty over a three-day meeting in October 2020 and 2021 wilh 1,285 and 1.414 Partpants respeclivety. Page 5
TrIE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limited by Guarantee} TRUSTEES. REPORT ICONnNUED) FOR THE PERIOD ENDEO 31 DECEMBER 2021 ISPAD organises and runs. with volunteer experts. an annual researchrien1ed Scienc School for Physicians {held virtualty in May 20211, as wdl as a Science Sch¢1 for Allied Healthcare Professionals working in diabetes (held wrtualty in October 20211. Applieations a eixnpelrtNe for both sthools each year. Visiting Feliowships allow young physicians and heahCafe professionals to study research techniques and prepare them to sel up research, either in collaboratKffi with the cenlre in whh they study, or to initiate research in a similar area In a more independent manner by provKling handsthon experience in an established Centre of Excellence of research in the domain of interest. ApPIntS present a research proposal for their study as well as references. with letters of support from their hospital or universty arml from the head ol the research centre to which they are appIn9 Idirecte<l by an ISPAD member) attesting lo the applicanl's acceptance al the centre lo pursue the research project as presented. The accepting ISPAD member volunteers their time and centre resources for the project. The lunds allryw the 1pnI to Iravel lo the cenlre and provide support for accommodalion. Since 2017 ISPAD collab¢vates the Juvenik Diabetes Research Foundation IJDRFI and awards 4 research fellowship. 25.000 dollars exh, and as of the calendai yeai 2019. 10 Alan Drash fellowships, of 7,500 ddlars each. The appltcalions are rewewed by the Trustees and Ihe Advtsory Crxnmittee who rank them on the qualty of the application and potential beneffts lo the applicant. The suecessful fecipient provides ISPAO with a feport on the project and is encouraged to submit an abstract to the annual meeting or a paper to the ISPAO journal. Grants from G•neTal Funds Travel grants are for young physi¢ian$ and healthca professionals whose abstract$ have been accepted for presentation at the Annual Confence. Due lo the pandemic. the "Travel Grants. We replaced by °Support Grants" for the Annual Conferences 2020 and 2021. These grants covered the costs ofthe registratn fee. The abslra¢l quality Iscoring as pei revwing pr¢xess by the Abstrxl Committee) as well as the ¢ountry of residence and profession were part of the sele¢tw criteria for allctsting these grants. Applications Irom Lower Income Counlrs {as per Wodd Bank classification) and All*d Heathcaie Professionals were eyplicilly encouraged. ISPAD arranged the first virtual edition of the scnce Schfxjl for Healthca Professionals for a 24ay course designed for fifteen healthca professionals in the fiekl of chiklhotsj diabetes to learn aboul research development. statistics and grant wrilin9. Grants Supported by Funds from Reslricted Grants Grants are obtained for the Science School for Phy5ich?ns for a 54ay course foi approximately twenty young physician scientists lo learn how lo design a research study, appty proper statistics and wrrte grants. These grants were provided in 2021 by Iwo comp5. Volunteers Members of the Society partiupate in all aspects ofthe knety e.g.: serving on the Adwsory Council serving as convener and organising wnmrttee mmbers forthe Annual COnferere serving on the ScientifK Committee reviewing abstracts for the Annual Conference acting as faculty lor the Science Schools and post graduate cou(ses serving on writing commrttees for the Clinical Practice Guidelines advocating for children wilh diabetes at k¢al. regiMal and intemational ve15 workin9 with sponsors to increase contributions attending the Annual Conference (primary fund-raising evenl) serving as PTeceplor5 for Visiting Fellows providing leadership in diabetes care for chddren and adolwents localty. Page 6
THE INTERNATIONAL SOCIETY FOR PEDIATrIC AND At)OLESCENT DIABETES IA Company Limited by Guarantee TRUSTEES. REPORT ICONTINUEDI FOR THE PERIOD ENDED 31 DECEMBER 2021 Members The IntematKJnal Society for Pediatric and Adc4escent Diabetes has members from more than 100 countries. A membership directory can be found on the ISPAD website 111_1$pad.0rgl. FINANCIAL REVIEW ANO RESULTS FOR THE PERIOD Financial Review The Current period is for the 18 monthyrKx4 ended 31 December 2021 1.2021,). The prior period is for the year ended 30 June 20201'2020'1. During the financial peric¥J 1 Juty 2020 to 31 December 2021. experltUre lolalled £552.306 12020.. £606,696) and income was £819.264 {2020: £635.1541. Our financ1 goals are to mwntain 5uffiuent funds hekl in reserve lo assure Ouf Continued existence under difficult financial situations (poor income years, and unusual economic ts"mes}. while we continue to support funding for Science Sch¢)ols, P.ost Graduate Courses, the Allan Drash ClinKal Fellowship, Researeh Fellowship. Travel Grants. Pedialric Diabetes, Memberships, and specwl inrtialNes. One of the challenges of hokling our Annual Conferences in drflerent ktations around the worfd is the wdely Vang costs and benefrts from Ihem. The 2018 Conference in Hyderabad, India was a successful Conference in raising awareness across the Trmder region. bul resulted in a negative balance. while the 45th Annual Conference in Boston. USA in 2019 resutted in a posrtive balance. The Annual Conferences in 2020 arKI 2021 were both virtual, with good attendance as Mentd and they resulled in positive baLCeS. A Crucial element of our charitable aims is to facilitate access to science and education, especialty for young heahh professionals invofve<l wth diabetes. To this end we support travel grants (scaled according to geographical localionl and specral travel gonts {fiJll payment of travel, registration and accommodation for membefs from the developing world). Starting from Juty 1. 2020. ISPAD has reduced membership and regi51ralion fees for members from Upper-mhldle4ncome countries as well as waived membership fees for Low- income countries. The COVID-19 pandemic has defin"¥ety affected the finance5 of ISPAD in the pTevious years and will continue to do so also In the year5 to come (see below). We e therefore, since February 2020. worked hard lo infom members and corporate memberslsponsor5 about the new srtuations we are facing. In order lo maintain our activities, ISPAD must in the coming years focus on keeping eosts drmn. as we expeel that income will likely be reduced. This is both because we, like other SocÈties, expect a reduction in sponsored income as well as reduced conference income due to reduced number of attendees as well as huher eonference inplemenlalion costs le.g. venue rental costs. speaker ttavel expenses). Reserve5 Policy Our policy is lo maintain serveS of sufficient furKls lo provKle orooing support for at least Or year of ChaTIIy activty. The balance of total reseeS at the year end was £1,152.869 12020. £885.9111 of which £1,067,861 12020." £843,665) was free reserves. this c¢)mpares witti £817,652 of total income in the period ended 31 December 2021, and £85,00812020.. £42,246) was restlted. confence income is very unpredictable and the CLITrenl finanaal climate demands that we hokl a sluhtly increased reserve. This is considered to be prudent also in light of the fact that rpOrate sponsorship has become rnore challenging to oblain. Investrnent Pollcy and Objectives The overriding philosophy and polry is lh* the Charity will take only mininal risk in order to preserve funds. The objectives are lo gamer when possible, reasonable interest on held funds without placing reserves or day-to4ay funds al risk. Page 7
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limited by Guarantee) TRUSTEES, REPORT ICONTINUEDI FOR THE PERIOD ENDED 31 DECEMBER 2021 Key rlsks and uncertainties As all charities, ISPAD has been facing increased risks and uncertainties due lo the COVID-19 pandemic. Even though the pandemic cyentty has slowed down, we still expect Changes and new challenges due to changes in ie. willingnes$ lo Iravd, being pawng members of the So¢ty and sponsoring the Socth. This Eeads to continuous drflicutties regarding both predthd income as well as expenses. Income.. During the P¢JeMic. the lotsl number of members for the ffirst time in several years decreased. Al ISPAD. we have experienced a stable increase in total membership numbers over a long Perd. In 2020-2021, we experienced a decTease of approximalety 20%. Thi$ was mainty due to the needed repeated wrtual ISPAD Conference 2021, as in 2020. Even though the virtual Conferences were well attended. we missed the effects we usually ObSee localty. In 2019-2020 we gained a sKJnrficanl amount of new members from North America due to ISPAD 2019 in B051on, while we had a Iremendous increase n members from Ind and neighbouring countries due to our conference in Hyderabad in 2018. The obvious reason for this local effect is a reduced conference fee for pawng members. This effed was complelety missing for ISPAD Virtual Conference 2020 and 2021. We are working hard lo maintain our total number of members, and hope that ISPAD 2022 on site in Abu Dhabi wim increase the numbers of members. both in the Region as well as Woawde. Regarding Corporate Membership and Sponsorship. Wffth are extremety important sources of income for ISPAD. the situation is still uncertain. So far. all key sponsors have maintained Iheir commitments. Still, we are aware th the situation for many of our Corporate collaborators are uncert•'n, and we should not lake their 5UPPOrt for granted for the upcoming years. The conference income for the fiscal year 2021 was as expected. due to the high lever of sponsorship income and lower expenses than wrth an in-person event. Regarding the on-stte Conference in Abu Dhabi 2022, we expect a negative balan. This is both because of en expected k)w number of attendees and redueed sponsorship income. Still this is in line wrth the overall aim of ISPAD (as previously described). and the event is thought to raise knowledge and awareness of diabetes in a regn of the world that up to dale never has hosted an Annual ISPAD Conference. TherefcKe. this expected negive balance has been included in the budget, and will not psent a maJoT ehallenge for the o¥ernll financ1 stiualion of the sety. enses.. There are still uncertainties with respects to the alllxation and ftymat of several of ISPAD core aclmties. This includes our science schoo15, both for physicians and healthca providers. the ASPED4SPAD-Lilly Academy. CDIC training and finalty the Allan Dra5h fellchvships. The restricted funding from dtherent sponsors for these adivrties wll depend on the activrties, tomal Iin-person or virtuat), wheTeby some might be postponed to a later dale. These adNities a of course very mnportanl for ISPAO as society. and we have to be flexible, dynamic and pragmatic lo maintain as many as them as well as possible desprte Ihe pandemtc. In summary. there are more risks and uncertainties than usual in the current situation. Nonetheles5, the financial situation is very safe within the fiscal year 2021 due lo headroom given by the hNJh level ol reserves. The Trustees undertook detailed plannirYJ and forecasting with dosety monitorirJ of the siluatson Sin the beginning of the COVIO-19 pandemic. Due to thi5. the Trustees believe that the ChariVs financial resources. strong reserves position and contsngency planning is sufficient lo albw the Charity lo continue as a going concem lor the foreseeab future. being al ¥$1 12 months from the dale of approval of these financial slatemenls. There are no material uncertainties about the abilty to contsnue and therefore the financial statements have been prepared on a going conrn basis. Looking ahead ISPAD has increased eryagement vrfh p*nI adv¢Jcacy groups during this reporting year. has encouraged them to meet al Oilf Annual Conferences and to publ•se the work and mission of ISPAD. ISPAD has played a rn4or role in CommunallOn wrth the community about COVID-19 safe pradi¢es arKI effe¢ls on the dkabetes Page 8
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES {A Company Limited by Guarantsg) TRUSTEES. REPORT {CONTINUED) FOR THE PERIOD ENDED 31 DECEMBER 2021 community during 2021. Our Annual coftferen for 2022 wiu be on site in Abu Dhabi, with the opportunity lo participale also wrtualty. Mainly due to the COVID-19 pandemic, the financjal clwnate 1$ stili challenging and rules and regulations for support from industry have changed making (( more diffKuli for ISPAD to reeetve corporate membership fees or specific grants. We are gralefvl for those who have been able to conts.nue to support ISPAD. For thi5 reason, ISPAD offers drflerenl levels to become a corporate member or sponsor. with drfferent benefits. ISPAD. to enhance its relalKJnship with companies. organries a specffic and strategic meeting (Corporate Advisory Board Meeting) annually with all wnpanies during its Winter Meeting in February. Since 2019, this meeting has been tsking place adjacent to the A0 {Advanced Technologies and Treatments in Diabetes} in order lo enable maximum industry attendance. The invoiced year for corporate membership is now the Calendar year (January lo Deeemberl and hence the accounting will change. The accounting year was transth.oned from a July lo June financral year to a calendar year by January 1. 2022. In order to adjust to the calendar year, the fi$¢al year th* started on July 1, 2020 wos extended by 6 nnthS to end on December 31, 2021. Membefship payments are becomin9 illcreasingty important. The number of lapsed members might be significantly reduced by improving the payment process and the possibilities to interact wrth other members. In order lo improve payment of MbershIP fees and to overc¢yme some te¢hnKal issues, ISPAD has requested K.l.T Group GmbH lo improve the. membership system and exlend on the overall experience to enrol membe in ISPAD activities. Now, after 3 years from rts implementation the system appears to be working well and membership had been sleadity increasing every year until COVID-19. We hope lo see an increase duwing 2022 because of the Annual Conference in Abu Dhabi. amhough this is drff¢cutt to predict wrth certainty. We anticipate that ISPAO will likety face the late consequences of the COVID-19 pandemic in the Upming fiscal years. We expect that some corporate member5 and sponsors may wlhdraw a$ their financial situation is uncertain. Allhough others may become new members. we may see a Teduclion In total corporate members and sponsorships. The diffieukies in organising the Annual Conference on-srte may relum. if so we are unsure of how Virtual Conferences will affect both the attendance to the ¢onferer4ce ((self and the total numbers of ISPAD members. If we hopelulty are to arrange on-site actiwlies in the future as planned. expenses may likely increase as a consequence of hwher inlemalional aldine expenses. Therefore. mainlaining reserves of sufficient funds ale mole important Ihan ever for ISPAD. We have also inrtiated a Sed accounting system for invoicing to be perfomied by K.l.T. Group in conjunction with and approval by the ISPAD Treasurer. This system is designed to prowde redundancy and avoid missing ¢)pportunities for ISPAD funding. Charlty Govemanee Code ISPAD aims lo address the seven https.'II.Ch3ntyg0¥ernanCeCOe.Ofy1enIfronI-p3Ye principles Charity Govemance Code Oiganisational purpose." to facilrtale the missth of ISPAD to Nnprove the lives of children, adolescents and young adults with diabetes wod(IMde. To do thrs we provide forums. both Wren (guidelines, e-Learningl and fa¢e-tO-face (ScnIff meetings, science schools for phySlan$ and for allied healthcare professionals, and poslgraduale courses). lo physian5 and heatthcare professionals who provide care for young people Nwth diabetes. We have three main pillars lo aChve our mission.. scien. education and advocacy. Leadership,. the TnJstees comprise an Execulrve Board and are advtsed by an Advisory Committee. We take collective responsibih'ty for the Board's decisions. The roles of each Trustee are clearly idenb"f (Winter Executive Meeting February 20201. Since 2017, the Executive Board now includes a Communicatn$ Director to facilitate effeclNe ccffiMunicatn with the membership and communty. Integrity.. the Executive Board acts with integrrty and is conscious of how it is perceNed by the membership and the public. A corporate liai50n officer was appointed in February 2018 to assist with communication and perception in the community. the"Oiabetes Online Communw including con5umer"bloggers". We faeililate their meetings al our Annual Conference and meet with them at meetings organized by the Pa9e 9
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limited by Guarantsel TRUSTEES. REPORT {CONTINUEDI FOR THE PERIOD ENDED 31 DECEMBER 2021 consumer organizalion Chiklren Wrth Diabetes (February 20201. Confiicls of interest are declad. Decision-making, risk and control.. the Board makes sure that operational plans and budgets are in line with the charity's purpose. The Board invested in foNard planning by expenses for represenlalives lo meet and teach in India1201&20201. the country with the second largest number of thildren wrth diabetes. and in Africa12019. 20201 Boaid effectiveness". the Boacd ads as an 8ffectNe team and ¢nUrag8S Members of the Advisory Board to set up Spla1 Inte$1 Groups al the Annual Conference in October 2017 onwards. Trustees are iefleclive of their perfomiance and discuss areas that can be strengthened. Equality, Diversty and Incluston.. the Board encourages diversty in the mernbership of committees. and in special non-physiuan positions on the Adwsory Board. Openness and accountsbility," the Board comlnunicates with the membership by the Annual General Meeting and by monthly newsletters sent by email. The Preshlenl writes special messages since 2017 which can be sourced on the SO¢$ websrte. The Annual Report is circulated lo the Membership and is available to the Public. Statement of Trustees. Responsibil•ties The Trustees Iwho are also directors of the Internaana1 SietY for Pediatn"c and Add8ent Diabetes for the purposes of company lawl are responsible for preparing the Trustees, Annual Report and the financial siatements in accoidance %wth appltsble law and United Kingd(*n Generalty Atcepled Accounting Practice (United KirvJdom Aeeounting Standards). Company law requires the Trustees to prepare financol statements for each financial year. Under company law the Trustees must not approve the financial ststements Un8$ they are satisfied that they give 8 true and fair view of the slate of affairs of the Charrtable Company and of the incoming resource5 and application of resource5, including the income and expenditure, of the Charrtable Company for that p8ricwJ. In preparing these financial slalements, the Trustees are required to-. gelecl suitable accounting polic5 and then apply them consistentty." observe the melhc#Js and principles in the Chanties SORP., make judgments and estimates Ihal are reasonable and prudent., state whether applicable UK accounting standards have been follwed, subpct to any material departures disclosed and explained In the finanual staternenls',and prepare the financial slalements on the goiry COnM basis unle55 it is inappropriate to presume that the Charrtable Company will continue in business. The Twslees are sponSible for keeping adequate accounting records Ihal are sufficient lo shcpw and explain the Charitable Company's transactions, disclose w¢th reasonable accuracy at any lime the financial position of the Chantable Company and enable them to ensure thal the finanaal statements compty wrth the Companies Act 2K6 and the provisions of the Chantys constrtution. They are also responsible for safeguarding the assets of the Charity and her for taking reasonable steps for the prevention arKI detection of fraud and other irregularities. The report of the Trustees has been prepa in accordance with the special pwsions relating to small companies subjecl lo the small ecrfnpan fegime within part 15 of the Companies Act 2006. Approved by the Board of Trustees of The Internatnal Society for Pedialric aThJ Adolescent Dtheles on and signed on its behaw by". Df Lars Krogvold Trustee 8 November 2022 Page 10
THE INTERNATIONAL SOCIEry FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limited by Guarantee) INDEPENDENT EXAMINER'S REPORT FOR THE PERIOD ENDED 31 OECEMBER 2021 Independent Examlnerfs Report lo the Trustees of The International Society for Pediatrfc and Adolescent Diabetes I'the Charity,) I report lo the charity Truslees on my examination of the accounts of the Charity for the perKKI ended 31 December 2021 which are set out pages 13 to 32. This report is made 501ely to the charrtab compan¥s trustees. as a b(, in accordance wrth Chapter 3 of Part 16 of the Companie5 Aet 2006 and the Charitab companys trustees as a body in accordance with section 154 ol the Charities Ad 2011. My independent examinerfs work has been undertaken so that I might state to the charitable compan5 Iruslees those matter5 1 am required to state lo them in an independent examiner's report and for no olhef purpose. To the fUlt extent perrnrtted by law. I do not accept or assume responsibility to anyone other than the charitable company. the Charitab companys members as a body and the charitable companys trustees as a bJY for my indeper¥Jenl examinerfs work. for this report. or for the opinions I have formed. Responsibilities and Basi5 of Report As the Trustee5 of the Chanty land its directors for the purposes of company lawl you are responsible for the preparatson of the accounts in accordance the requirements of the Companies Ad 2006 {Ihe 20C6 Acl'l. Having satisfied myself that the accounts of the Charity are not required to be audrted under Part 16 of the 2006 Act and are eligible for independent examination. I report in respect of my examinalTron of the Charitys accounts card out under section 145 of the Chafities Act 2011 (Ihe 2011 Act'l. In carrying out my examination I have followed the Directions given by the Charity Crynrrission under section 145151{bl of the 2011 Act. Independent ExamineV5 Statement Since the Charity's gross income exceeded £250.000 your examiner must be a member of a l)ody listed in section 145 of the 2011 Acl_ l confirm that l am qualffied to undertake the examination because l am a member of The Association of Chartefed Certified Accountants. which 15 one of the lisled bodies. I have completed my examination. I confirn that rKJ matters have come to my attention in connection with the examinalhjn givrng me cause lo beIve.. accounting records We nol kept in respect of the Charity as required by secbon 386 of the 2006 Act. or the accounts do not accord wrth those records", or the accounts do not compty ¥h the accounting requirements of sectitin 396 of the 2006 Act other than any requirement that the accounts give a Yrue and fairf wew whh is not a matter Conside as part of an independenl examination", or the acc¢)unls have not been prepared in aceothrte vrith the methods and princip$ of the Slalemenl of Rec(xnmended Practice for accounting and reporting by charities {applicable to charrties preparing their accounts in accordance with the Financial Repo.n9 Standard applicable in the UK and Republic of Ireland IFRS 10211. I have concerns and have ¢cme ro$S no other matters in connection with the examination to which attention should be drawn in thi5 report in order lo enable a proper understanding of the accounts to be reached. Page 11
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES {A Company Lwnited by Guaranteel INDEPENDENT EXAMINER'S REPORT (CONTINUED) FOR THE PERIOD ENDED 31 DECEMBER 2021 Signed.. Dated: 09 December 2022 Tara Westcott FCCA Crowe U.K. LLP Fourth Floor Sl James House St James Square Chellenham GL50 3PR Page 12
THE INTERNATIONAL SOCIETY FOR PEOIATRIC AND ADOLESCENT DIABETES IA Company Limlted by Guarantee) STATEMENT OF FINANCIAL ACTIVITIES IINCORPORATING INCOME AND EXPENDITURE ACCOUNT} FOR THE PERIOD ENDED 31 DECEMBER 2021 Unrestricted Restricted Total funds funds funds Total 18 months to 18 months to 18 months to funds 31 December 31 December 31 December 12 monlhs lo 2021 2021 2021 3Q June 2020 Note Income fvom: Donations Charitable activities.. Membership income Coporate sponsorship inujme Corporate membership JDRF Fellowship Conference income Olher charrtable adivrtie5 Invèslmenls Other income.. Royalties 400 400 3.469 138.324 138.324 138,841 209.489 94.936 225,738 1,612 135.292 161.960 150.227 80,631 68,522 138,841 209.489 94.936 225.738 1.612 870 34.183 9.924 9.924 Total income 583.875 819.264 635, 154 Expenditure on: Charrtable actiwties 359.679 192.627 SS2,306 606,696 Total expondiluFe 359,679 192.627 552.306 606,696 Net movement In funds Rè¢oncillation of funds- Total funds brought forward Net movement in fvnds 224.196 42.762 266,958 28,458 843.665 224.196 42.246 42.762 885,911 266.958 857,453 28.458 Total funds caled forrd 1.067,861 1,152.869 885,911 The notes on pages 16 to 32 fcffii part of these financial statements. Page 13
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES {A Company Limited by Guarantee} REGISTERED NUMBER: 06641016 BALANCE SHEET AS AT 31 DECEAIBER 2021 31 Dember 2021 30 June 2020 Note Current assets Debtors Cash at bank and in hand 203,178 1.416A07 57.328 1,182,377 1.619,585 1.239.705 Credi(ors". amounts falling due wrthin one year 12 (456.448) (320.364) Net current ass•ts 1.163,137 919,341 Totsl assets less ¢urTent liabilities 1.163.137 919,341 Credrtors." amounts falling due after more than one year 13 110.268 133.430) Total net assets 1,152,869 885.911 Charity funds Restricted funds Unreslr¢cled funds 14 85.OD8 1,067.861 42,246 843.665 14 Total funds 1,152,869 885.911 The Charity was entitled lo exemption from audit under section 477 of the Corry)anies Ad 2006. The membef$ have not required the company to r)btain an audit lor the pertsj in question in accordance wrth seCtn 476 of Compans Act 2006. The Tnjslees adtnowled9e Ihwr responsibilit for ccvnplwThJ with the requirements of the Act with respect lo accounting recofds and preparion of finanoal st*emenls. The financial statements have been prepared in accordance wth the provisions appluble to entities subj'ect to the small companie5 regime. The financial ststements were apwoved and authonsed for issue by the Trustees on and signed on theii behalf by". Dr Lars Krogvokl Trustee 8 November 2022 The notes on pages 16 to 32 fom part of these financial statements. Page 14
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES (A Company Limited by Guarantee) STATEMENT OF CASH FLOWS FOR THE PERIOD ENDED 31 DECEMBER 2021 31 D•cember 2021 30 June 2020 Note Cash flows from operntlng activities Net cash fr¢Jm operating activiti.es 16 234.030 65, 166 Cash flows from investing activities Interest recwved 870 Net cash provlded by Investing aetivitles 870 Change in cash and cash equlyalents in Ihe perlod Cash and cash equivalents at the beginning of the perK)d 234.030 66.036 1,182,377 1, 116,341 Cash and cash equlvalents at the end of the period 17 1.416.407 1. 182,3T7 The N)tes on pages 16 to 32 fomi part of these financial statements Page 15
THE INTERNATIONAL SOCIETr FOR PEDIATRIC AND ADOLESCENT DIABETES (A Company Limit•d by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2021 General Infofmatlon The Inlemalional Swiety for pedIatr and Adolescent Diabetes {ISPAD) is a tharitable company, limited by guarantee. Iregistralion number 06641016 England & Wales) and the Charity Commission (charity number 1126927). The registered office address is Harrison Clark Riekerbys Limited, Ellenborough House. Wellington Streel. Cheltenham. Glouceslershire. GL50 1YD. Accounting policies 2.1 8asis of preparation of financial statements These financial stslements present informats.on about the Charity as an individual undertaking. The current pef 15 for the 18 monlh-perKJ ended 31 December 2021 {'2021'}. The prior period is for the year ended 30 June 20201.2020.). The financial ststemenls have been prepared in accordanee with the Charities SORP IFRS 102) - Accounting and Reporting by Chariti"es". Statement of Recommended Practice applicable to charities preparing their accounts in accordance wth the Finanaal Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021 (effective 1 January 20151, the Financial Reporting Standard applicable in the UK and Republic of Irelarml {FRS 1021. the Companies Act 20CE and the Charities Act2011. The Intemalional S¢xty for Pe¢jIatr and Adolescent Diabetes meets the definrtion of a public benefit entty under FRS 102. Assets and l1abilrtS are initialty COgnised at historical cost or transaction value unless otheiSe stated in the relevant accounting policy. 2.2 Going'concern The Truslees have undertaken detailed planning and forecasting and continue to closely monitor the long-term financial impact of Cov119 a5 well as the developing global financial situation. As described in the Trustees. Report membership income has been impacted and there are uncertaint$ over fvture corporate inco and income and costs associated with conferences, fellowships and events. Despite the tunt circumstances the Trustees belve that the Chartty's finanehql resources. strong reserves position and contingency planning is sufficient to allow the Charity lo continue as a 90ing concem for the foreseeable fLrture. being al least 12 months from the dale of approval of these financial statements. There are no material uncertainties about the abilty lo continue and therefore the financial slatements have been prepare<l on a gohng concem basis. 13 Income Income is recognised in the financial statements when the Charity has enlrtlemenl to the funds, it is probable that the income wll be received and the at7v)unt can be measured reh'abty. Membership incoff is r091$ed in line with the fla1 year. Membership income for future year$ is defefred. Page 16
THE Ii¥fERNATIONAL SOCIEry FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2021 Accountlng pollcies Iconllnuedl 2.4 Expenditure l eypendrture 1$ accounted for on an accruals basis. Supp)rt costs are apportioned to eost aclNrties based on the estimated amoLtnl attributsble to that cost in the year on the basis of the estimated lime spent on that activty. The irrecoverable element of VAT is included with the item of expense to which it relates. Charitable ath"vrties comprise all expeThJiture Inrre{l dir8Ctty relating to the obj'eds ol the Charty. Grants are recogni5ed when a constru¢tNe obligation arise5 that 511$ ¥i the payment being Unavoab1e. Govemance costs indude the costs connected with the Chartys eonstitutional and slalutory requirements. Charitable acts'vities are costs Ine¢j on the companls ¢)perations, inclLKling SUPPOrt costs costs relating to the govemance of the company apportK>ned lo charitable activrties. 2.5 Foreign currencies Monetary assets and IHbilrttes den¢)minated in fooign currencies are translated into sterling al rates of exchange ruling at the reporting date_ Transactions in foreign currenaes are translated into steding at the rate ruling on the dale of the transaction. Exchange gains and losses are recognised in the Slalement of Financial Aclrvitses. The functional currencies of ISPAD S eonsK4ered to be Euros and US Ddlars because these are the curreneies used by the members of the S¢xiety in the primary economic environment in which the charity operate5, Eurcye and the rest of the workl. The financial statements are presented in pound5 sterling. 2.6 Taxation As a registered Charrty the entrty is eolrtknl lo taxats.on exempts.ons on all f(s income and gain5, properfy apPld for rts charitable purposes. 2.7 Debtors Trade and other debtors are renISed * the settlet amount after any trade discount offered. Prepayments are valued at the amount prepaNJ. 2.8 Cash at bank and in hand Cash is repseAted by cash in hand and dep05ts wrth financial institutions. 2.9 Creditors Creditors a recognrsed orbce there is a kgal or con$truotNe obligation that commits the Charty lo the obligalpJn. Page 17
THE INTERNATIONAL SOCIEfY FQR PEOIATRIC AND ADOLESCENT DIABETES (A Company Limited ty Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 310ECEMBER 2021 Accounting policies (conlinued) 2.10 Financial instruments The Charty onty has financol assets and finanoal liabilibes of a kind Ihat qualify as basic financial instruments. Bas financial instrument5 are In"alty recoJnised al transaction value and subsequently measured at their settlement value. Ill Fund accounting Unrestricted funds expendable at the dwetion of the Trustee$ in fvrtherance of objectives and administrion of the Charrty. Resth"cted funds are to be used for SPecrfd purposes Jaid dcwn by the donor. Expenditure for those purposes 15 charged to the restrKted fuThJ. Ciitlcal accourting estimates and areas of judgement Preparation of the financial statements reouiTe5 management to make any signffjtsnl estimates and judgements where necessary. The items in the financial statements where material esbmales and judgements have been made indude- Impairment of d•blors The charity makes an estimate of the recoverable value of membership debtcrfs. When assessing impaimnt management considers hi5ton¢al exper*nce. See note 11 for the nel Carrn9 amount of debtors. Investment income Unrestricted Total funds ftsnds 18 months 18 months to31 to31 December December 2021 2021 Bank interest unStricted Total funds funds 12 months to 12 months lo 30 June 30 Jun 2020 2020 Bank interest 870 870 Page 18
THE INTERNAnoNAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limited by Guaran¢ee} NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2021 Anatysi5 of èxpenditurè on charitable a¢livities Summary by fund type Unrestrl¢ted Restrlcted Total fund5 funds funds 18 months 18 months 18 months to31 to31 to31 DKember December December 2021 2021 2021 berSh costs Conference eosls Grants and Prizes (note 7) ISPAD Science School for Physioans ISPAD Science School for HeaJth¢are Profession* PETCAJPETCWA Research and projec15 Alan Drash Discovery of Insulin Ichiklren's B¢x)kl Dexcom Guidelines JDRF Fellowship Other 172,874 44.187 19,451 24,148 8.127 1.182 22,149 172.874 44.187 28.902 21,543 8,127 1.182 88.737 1.612 2S.098 156,717 3,327 9,451 12.6051 66.S88 1,612 25.098 92,483 64.234 3.327 Total 2021 359.679 192,627 552,306 Page 19
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT OIA8ETES (A Company Limiled by Guarantee} NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2021 Anatysis of expendlture on Charhable aclivities l¢ontinued) Surnmary by fund type IntInued) UnTrstitled ReslriGled Tolal funds funds funds 12 months lo 12 months to 12 miynths lo 30June 30 June 30 June 2020 2020 2020 Membership eosls COnfereTh costs Grants and Prizes (note 7) ISPAD Seience School for Physiaans ISPAD Science Schod for Heahhcare Professionals PETCA Research and pr(Jiects Alan Drash SWEET proje E Learning Changing Diabetes in Children Icwnbodia) JDRF Fellowsh 109.062 23,036 54.527 11.021 19.838 24. 733 19.838 1, 102 2,204 109,062 22,036 74,273 49,005 67,633 24, 733 80.693 28,481 8,592 13.076 114,203 14,909 19,746 37,984 47,T95 60,855 27.3T9 6,388 10,872 81. 140 5.482 33.063 9.427 her Total 2020 309.055 297,641 606.696 Page 20
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limited ty Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2021 Anatysis of expenditure by activities Activities undertaken Support directly costs 18 months 18 months to31 to31 Deumber December 2021 2021 T¢tal funds 18 months to31 Dgcember 2021 Membership Costs conferen costs Grants and Prizes {nole 71 ISPAD Science School for physan$ ISPAO Science School for Healthcare ProfessJnals PETCAIPETCWA Research and projects Alan Drash SWEET project Changing Diabetes in Chdreft {Cambodl JDRF Fellowshp Other 172.874 33.225 3,322 4,429 4,429 172.874 44.187 28.902 21.543 8.127 1,182 88,737 1.612 25,098 156,717 10,962 25,580 17.114 3.698 1.182 22.149 1,612 25,098 92,483 64,234 - I'l 3,327 3,327 Total 2021 244.317 307.989 552,306 Page21
THE INTERNATIONAL SOCIETY FOR PEDIATrIC AND ADOLESCENT DIABETES IA cnpaThY Llmited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2021 Analysis of expenditur• by activities Icontinued) ActiVitS Support Total undertaken costs fvnds direclly 12 months to 12 months to 12 months to 30 June 30 June 30 June 2020 2020 2020 Membership costs Conference eosls Grants and Prize5 (note 71 ISPAD ScEnce School for Physicians ISPAD Science School for Healthcare ProfeSsYal$ PETCA Researth and projects Alan Drash SWEET project E Learning Changing 0beteS in Children (Cambod) JDRF Fellowshp Other 38.32T 11.015 52,231 37,984 47.795 23.631 60.855 2T.379 6.388 10.872 81, 140 70.735 11,027 22.042 11,021 19.838 1.102 19,838 1. 102 109.062 22.036 74,273 49.005 67.633 24. 733 80.693 28.481 8.592 13.OT6 114.203 14,909 33.063 Total 2020 408. 178 798.578 606.696 Page 22
THE INTERNATIONAL SOCIEfi FOR PEDIATRIC AND ADOLESCENT DIABETES (A Company Limilgd by Guarantoe NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2021 Grants and priz•s 31 December 18 months 10 31 12 months to December 30 June 2021 2020 30 June ISPAD Prrze for Achievement Special Travel Grants Young Investigator Awar(I ISPAD Prize for Innovation Leslradet Award Standard Tiavel Grants Hero Award Patient Advocates 2.374 1.868 1.164 2.470 2A15 13.257 1.028 1,004 5,069 22,968 3,274 6,035 5.368 9,412 105 25,$80 52,231 Details of the winners ol ISPAO prizes and felkxshp$ is awlable at: www.ispad.orgDpage=ISPADPiizeWinnets. All grants, prizes and lelThvships are to individuals. Page 23
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2021 Support costs 31 Ot¢ember 18 months to 31 12 months to December 30 June 2021 2020 30 June Meeting expenses Insurance Bank Charges Credrt Card fees Management charge Printing, postage and ststionery Advertising and promotion Goveman¢e costs Independent Examinefs fees Legal fees Exchange lossl (gain) Webinars 532 1.472 3.339 7.408 190.378 265 6.626 49.9T5 1,047 3,950 6,968 122, 139 530 16.361 12.640 2,246 74.490 8.595 13.631 555 (16,578J 307,989 198.578 Exchange rat• gainlloss This is not a trading gain as ISPAD does not trade cuen¢1es. It ts an 'accounling adjyslmenv and represents the drffenee irb value of non-sterting balances al the year end in comparison to the start of the year where diffenI exchange rale5 were in effect. As an eXarnp a balance of $10,000 at the start of the financial year might be worth £7,600 {* a USDIGBP exchange rate of 0.761 and al the end of the yeai that mi9ht have changed lo £7.870 {al a USDIGBP exchange rale of 0.7871. This woukj result in an apparent gwn of £270 while in fa¢t there h•J been no change to the $10.000 held. The fol9n exchange Ioss 15 incI4ed in 5UPWt Costs and wa5 £74.49012020". £16.578 gain). Page 24
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES {A Company Limited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2021 Indepondent examinerfs remunernlion 18 months to 31 12 months to D•cemb*r 30 June 2021 2020 Fees Payats to the Ch8nWs independent eXIner for the independent exarninalion of the Chwty's annual accounts Fee5 payable lo the Charitys independent examiner in respect of.. l assurance sefwces not included above 9,640 3.000 10. Trustees. r•muneration and expenses During the period. Tr) Tnjstees received any remunerathm or other beneffts (2020- £NIL). During the period ended 31 December 2021. expenses totalling £532 were reimbur$ed or pa"Ml directly to 4 Trustees (2020- £11.488 to 5 Tnisteesj. Expen$ related to travel. a¢wnodation and subsistence. 11. Debtors 31 De¢emb•r 2021 30 June 2020 Due within on• y•ar Trade debtors PpaymentS and accwed income 197.868 5.310 49,839 7,489 203.178 57,328 Page 25
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES {A Company Limited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2021 12. Creditors: Amounts falling due within one year 31 December 2021 30 June 2020 Trade creditors Accruals and deleffed income 190.907 265,541 105.049 215,315 456.448 320.364 31 December 2021 30 June 2020 Deferred income at 1 Juty 2020 Resources deferred during the perth Amount5 Teleased from previous periods 158,227 261.708 11S8.227 125. 137 141.906 (708.816) 261.708 158,227 Deferred income rel*es to membership subscriptions, coOrate mernbership for future years and the JDRF Feltuwship. 13. Creditors: Amounts fallin9 due after more than one year 31 Decernber 2021 30 June 2020 Accruals and tlefetted income 10.268 33,430 Page 26
THE INTERNATIONAL SOCIEry FOR PEDIATRIC AND ADOLESCENT DIABETES IA C¢>mpany Limited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2021 14. Statement of funds Statement of funds - Current perlod Balance at 31 8alan¢e at 1 July 2020 Dember 2021 Income Expenditure Unrestrlcted funds General FurKls- all funds 843,665 583.875 1359.679) 1,067.861 Restrlcted funds Alan Drash Fellowship Innovation Prize Wedcasting sponsorship Young Investvjalorfs Award Lestradet Award Discovery of Insulin ASPED-ISPAD Llly Diabetes pradUate course 66.586 4.190 {66.5861 12,472} 11.928 3,254 13.646 3.254 6.877 10.174 2.095 7.542 1.612 {1.1641 {2.4151 {1.6121 5,047 8,809 8.809 2,453 34,816 3.911 1.068 JDRF Fellowship Novo NordiskJLily SSP Lily Prize for Achievement Hero Award ISPAD Guidelines 2022 94,936 24,949 6.285 2,096 25.098 192,483 2.605 12.374) 11.028) 12S.098 7.262 42.246 235.389 1192,6271 85,008 Total of funds 885.911 819.264 1552.3061 1,152,869 Page 27
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limiled by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEM8ER 2021 14. Staternent of fvnds Icontinuedl Statemenl of fvnds- prior period Balan at 30 June 2020 8818nce at l July 2019 Tr8nsfe in/oul Inc¢)me Expenditurg Unrestricted fvnds General Fur 5,277 392,563 (309.055) f45. 120) 843,665 Rtrict¥d funds ISPAO SSHP Nairobi Education Prcyect Alan Orash Fdl¢Mhip Innovation Prize Wedcasting sponsorship Young Invesligalorfs Award Lestradet Award (4,927) 1.640 (130) 13,41Kl 3,254 4,925 5.361 6. 727 12.171 (47, 795) (5,482) (60,855) (6.035) 40.551 3.842 130 .60,855 11.928 3,254 5.946 5.047 4,295 5.054 (3.274) (5,368) (6,388) Discovery of Insulin ASPED4SPAD Lilty Dtheles Postgraduate course Lily-SWEET Proied JDRF Felkwship Novo NordiskJLity SSP LI Prize for Achievemenl ISPAD SSHP (339) 27,379 80.631 36.673 (27.379) {81, 14Q) (37,984) (5.069) (10,812) 509 8.573 7.262 525 {98J 70.970 52.176 242,591 1297,641) 45, 120 42,246 Total ol funds 857.453 635, 154 (606.696) 885,911 Page 28
THE INTERNATIONAL SOCIETY FOR PEDIATRIC ANO ADOLESCEMT DIABETES IA Company Limited by Guarantsel NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2021 15. Slatement of Funds {continuedl ISPAD Seience S¢hool for Healthcare Professionals This is funds used lo support the Sence School for Heamhcare Professionals which is a three day course in the field of chiklhc*)d dthtes to aboul research development. statistics and grant wri(ing. Nairobi Education Project The Nairobi Edu¢alion ProiKI is a johnl venture btheen ISPAD and ESPE IThe European Society of Paediatric Endo¢rinologyl to educate doctors from AfrKan countries in the management of endocrine diseases Including diabetes. Groups of Fellows are resident in Nairobi foT 6 months al a lime during which they receive tuition from visiting internats.onal expert$ who spend 24 week$ wth them. Alan Drash Fellowship Alan Orash was one of ISPAD'S founding membets arKI in his memory ISPAD offeTs a 6 week dinical fellowship. Applications are invited frcffi member5 below 45 yeaT5 of age. A port must be submrtled to the ISPAD Steering CL¥nmittee wrthin l year after fellowshy. The ISPAD Prize for Innovation in Pediatric Diabeles Care Sponsored by NovoNordisk within their DAWNTM Youth Inrtiative. thi$ prize is for any professional. group or indivKlual who ha$ made a SnIfiCant (rMmerCIall innovation Fn pediatric diabetes caie. DAWNT Youth is a global programme to guide the wider diatletes Community to address the unmet needs of young people wlh diabetes. their families, peers and healtheare professionals. This prize puls the focus on diabetes In childhc4)d by reCognis9 innovations to improve health and qualty of Te for children and young people. Webcasting The webcasting fund was initsally cwled for costs related lo ISPAD'S fi1 wekasling Plafform in 2014 (Annual Conference in Toronto). Since 201 S. ISPAD has a new Conference Resource Plaffomi, for which the lunding and tated costs are nthv managed as part of the conference budget, managed by K.l.T Grep. in dose collaboration wrth ISPAD. E-Learning New educational tods include Ihe web based e4eaming progfams. These allow a wider access to infomiation and a conlinw)us auto evaluatK)n. ISPAD has been invited by ESPE to develop the Diabetes Module in the e-leaming portal created by the team of ProfesSOT Sten Drop in Rotterdam. This Oiabeles odule will be based on our Clini1 Prarti Consensus Guidelines. ISPAD Members wll be able lo acces5 the frleaming pcKtsI. Dorothy Becker is the kad of the e-leaming project. The ISPADASPED Lllly diabeles postgraduate coutse The ISPADIASPEDlilty dk4betes postgraduate course {previousty described as the Post Grad Course Arabian) is an inrtvalive from ASPED In collaboration with ISPAD. The aim of the Coufse is lo empower and update physicians practicing in the Arab countries who are invofved in the care of young people with diabetes and is intended to be a platlom to Sh expe"Se. search and devekynenl in the field of diabetes. JDRF Fellowship JDRF ha5 Signed a MOU with ISPAD with the aim to award each year for three years starting in 2017, four grants of $25,000 to award the four best rese3h projects submitted by young researchers, who are ISPAD members, aged 40 or below. The grant coukl be spent in a hosting center of excellence bul also al Iheir own ¢entw. Page 29
THE INTERNATIONAL SOCIETY FOR PEDIATrIC AND At)OLESCENT DIABETES
IA Company Limii•d by Guarantwl
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
15. Stat•mgnt of Funds Icontinugd)
SWEEf Project
The aim of SWEET is to reduce Inequa1rt in access to aThJ quality of p•liatric diabetes care.
Shortcomings and inequalrtie5 in this care are mainty due to the undetying differences in system5, and the
most straightfoard solution to this problem is a netsrk of pedtriC diabetes cenlers worfdwide.
connected through common objectives and slandards. making rt possible to benchmark resources and
results. The SWEET registry was estsblished in 2008 for this purpose. The ISPAD@SWEET initiative
strives to include Centers from the developing wodd. Eli Lilfy gave É30,000 for the first year of the project
lo equally support both smaller and larger centers, in totsl eghl dinics. from developing COUntrS to
become respeclivety Center of Reference and ASsocle Centers of SWEET and start up a registry.
Novo NordisklLily SSP 2018
These are funds lo supFort the Sciertt School for Physicpns.
The remaining restricted fijnds are donatK•ns grants which must be awarded lo divla1S.
Hero Award
This award identifies and honours non
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 310ECEMBER 2021 15. Anatysis of net assets between funds Icontinuedl Analysls of nel assets belween funds - pfior period Unrestncted fvnds 30 June 2020 Raslricted funds 30 June 2020 30 June 2020 Current assets Creditors due within one year Credi(ors due in more than one year 1.129.116 (252.021) (33,430) 110.589 {68.3431 1.239, 705 (320,364) (33.430) Total 843,665 42.246 885.911 16. Reconciliation of net movement in lunds to net &ish flow from operating activlties 31 Deceffir 2021 30 June 2020 Net InMe for th8 period (as per Ststernent of Financial ActNit*sl 266.958 28,458 Adjustments for: Interest received Ilncreasell decrease in debtors Increase in creditors (870) 18, 621 18,957 1145.850 112,922 Net cash provided by operating activilies 234,030 65, 166 Page 31
THE INTERNATIONAL SOCIETY FOR PEL¥ATRIC AND ADOLESCENT DIABETES IA Company L#nited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2021 17. Analysis of cash and Cash equivalents 31 30 June 2020 2021 Cash in hand 1.416,407 1, 182,377 Total cash and cash equivalents 1.416,407 1, 182,377 18. Analysis of changes in nèt debt At31 December 2021 At 1 July 2020 Cash Ilows Cash at bank and in hand 1.182.377 234.030 1.416,407 1.182.377 234.030 1.416.407 19. Related party transactions There were no related paty transactbjns in this per or wrthin the previous year. Page 32